Hyperliquid Strategies Inc (PURR): Insider Trading, Congress Trades & Research | Tormere
PURR
$9.69-4.63%
Hyperliquid Strategies Inc
Market Cap
$1.9B
Live price × SEC shares (Aug 23, 2026)
Sector
Health Care
Industry
Biotechnology
Beta (raw)
—
Insufficient price history
P/E (TTM)
6.3
TTM to Jun 2026 · mkt cap / net income
Flagged input, hover for details
P/S (TTM)
202.6
TTM to Jun 2026 · revenue
Flagged input, hover for details
P/B
1.0
Mkt cap / shareholders' equity
Flagged input, hover for details
EV/EBITDA (TTM)
—
EV / TTM EBITDA
Loading…
Financial Statements
USD thousands
Q3 FY2025
Sep 30, 2025
Q2 FY2026
Dec 31, 2025
Q3 FY2026
Mar 31, 2026
Q4 FY2026
Jun 30, 2026
TTM
Jun 30, 2026
Revenue
500
2,626
6,334
9,460
Total operating expenses
288,046
(191,188)
(601,419)
(491,163)
Operating income
(287,546)
193,814
607,753
500,623
Pretax income
(286,668)
195,180
593,903
489,017
Income tax
17,795
42,670
123,010
183,475
Net income
(13,398)
(304,463)
152,510
470,893
305,542
EPS (basic) ($)
(13,183.92)
(7.43)
1.01
3.21
EPS (diluted) ($)
(13,183.92)
(7.43)
1.01
3.21
Weighted avg. shares (basic)
0
41,004
124,037
Weighted avg. shares (diluted)
0
41,004
124,044
Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-K filed Aug 27, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source
Reported Earlier, Twenty One Completes Business Combination With Cantor Equity Partners And Lists On NYSE Under "XXI" With Over 43,500 Bitcoin — Benzinga · 2026-10-30
Tormere — informational purposes only, not investment advice.
